RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abnoba Gmbh
• Treatments: Doxifluridine; Floxuridine; Viscum album peptide

Criteria

Inclusion Criteria:

• postoperative UICC stage Ib/II gastric carcinoma

• indication for oral chemotherapy with doxifluridine

• ECOG performance status 0 or 1

• normal liver and kidney function

Exclusion Criteria:

• inability to answer the QoL scales

• concomitant therapy with steroids or biological response modifiers

• individual hypersensitivity to mistletoe preparations

• pregnancy or lactating

• participation in another clinical trial